Catalogue MOVEO
Catalogue MOVEO
Wearable smart devices are increasingly important for supporting independent living among the elderly, particularly those with mobility issues. The prevalence of walking problems rises significantly with age, affecting 60% of individuals over 80 years old.
The Problem
Current walking aids and exoskeletons are inadequate due to their heaviness, battery limitations, high cost, and the need for training. They often serve different populations and purposes, such as paraplegics or balance assistance, and are associated with social stigma.
Solution: ExoBand
ExoBand is a soft, self-powered exoskeleton designed to enhance independent living. It uses advanced elastomer technology to optimize energy use, making walking less energy-intensive. The device is lightweight (~400g), comfortable, and can be worn discreetly under clothing. It is also affordable and reimbursable in Italy for those with a medical prescription.
Benefits
ExoBand significantly increases walking distance by up to 50% and is highly appreciated by users, as evidenced by testimonials from individuals with conditions like multiple sclerosis. It provides substantial benefits to both users and healthcare providers.
Achievements
ExoBand is a patented and CE-marked medical device, winner of the Prix Galien 2021, and is commercially available in multiple sizes. It has been scientifically tested and developed with patient support, achieving high user satisfaction across EU countries.
Market Segment
The target market includes patients with degenerative diseases in early to mid-stages of mobility reduction, elderly individuals interested in maintaining mobility, and athletes recovering from injuries. The potential market in Europe alone is 16.7 million people.
Contact Information
For more information, visit www.moveowalks.com or contact via email at [email protected] or phone at +39 049 261 4427 / +39 391 459 0627.
Catalog excerpts
Wearable Smart Devices for Independent Living
Open the catalog to page 1
60 million people globally has walking problems Walking problems are due to: 1. Neuromuscular degeneration • Stroke • Multiple Sclerosis (MS) • Parkinson Disease (PD) 2. Aging population Prevalence increases from 10% in people aged 60-69 years to 60 % in those aged 80+
Open the catalog to page 2
Current solutions do not address key user needs And to the limited healthcare resources available for clinicians and physiotherapists Walking aids • Different purpose (designed to help balance) • Low tech • Limited efficacy • Social stigma Heavy Limited by batteries Expensive (€30k-€40k) Require training to be used Different population s
Open the catalog to page 3
A soft and self-powered Exoskeleton for independent living • Walk using less energy • Passive – relies on advanced elastomer technology to conserve and optimize energy use • Wearable – functional and comfortable fabric • Lightweight – no bulky motors and batteries • Can be used with walking aids
Open the catalog to page 4
PATENTED TECHNOLOGY Based on bespoke cutting edge research
Open the catalog to page 5
ExoBand delivers important benefits to users and healthcare providers • The users need less energy to walk: the distance walked increases by up to 50% • ExoBand is extremely lightweight (~400g), comfortable and relatively unobtrusive and can be worn under clothing • It is fully reimbursable in Italy for disables with a medical prescripti
Open the catalog to page 6
Satisfied users After two months of use, with ExoBand I feel great. ExoBand makes walking, together with crutches, much easier and much less tiring. Antonia Iengo, 60 I have been diagnosed with multiple sclerosis since 2005 and walking has become difficult. ExoBand has been of great help, and allows me to be independent. Patrizia Tasso, 58 The first time I had to stop three times and I did maybe 300 meters. This morning I managed to do almost 600 meters without stopping. Benito Piasentin, 78
Open the catalog to page 7
Main achievements • Patented and CE marked medical device • Winner Prix Galien 2021 • Commercially available with 3 sizes plus baby • Scientifically tested and developed with support of patients • Satisfied users in EU countries • Established network of rehabilitati
Open the catalog to page 8
INDUSTRY & MARKET SEGMENT A completely new market segment Degenerative disease patients in the early/mid-stages of mobility reduction, i.e. those who can still walk and want to maintain this ability Elderly patients is a potential market of 16.7m people in Europe. Target users are those with an interest in maintaining mobility. Athletes who are recovering from injury and require temporary supports during their rehabilitation.
Open the catalog to page 9
Helping millions of people with reduced mobility www.moveowalks.com [email protected] +39 049 261 4427 +39 391 459 0627
Open the catalog to page 10